Related Experiment Video
Updated: Feb 20, 2026
Arthroscopic Management of Massive Irreparable Rotator Cuff Tears: Whole Rotator Cable Reconstruction Using Proximal Biceps Tendon Autograft
Published on: June 6, 2025
Management of Failed Rotator Cuff Repair in Young Patients
Bassem T Elhassan1, Ryan M Cox, Dave R Shukla
1From Mayo Clinic, Rochester, MN (Dr. Elhassan, Dr. Shukla, and Dr. Lee), Rothman Institute Orthopaedics, Philadelphia, PA (Mr. Cox and Dr. Abboud), MedStar Orthopaedics, MedStar Union Memorial Hospital, Baltimore, MD (Dr. Murthi), and the University of Utah School of Medicine, Salt Lake City, UT (Dr. Tashjian).
Insights
Managing failed rotator cuff repair is challenging, influenced by patient and surgical factors. Optimizing surgical techniques and considering biologic or tendon transfer options improves outcomes for revision rotator cuff repair.
Area of Science:
- Orthopedic Surgery
- Sports Medicine
- Regenerative Medicine
Background:
- Failed rotator cuff repair presents significant challenges, particularly in younger patients.
- Healing is influenced by numerous patient-related factors (age, tendon/bone quality, tear characteristics, comorbidities) and surgical variables (technique, timing, biomechanics, fixation, rehabilitation).
Discussion:
- Revision rotator cuff repair outcomes are variable, underscoring the need for systematic approaches.
- Biologic augments (e.g., platelet-rich plasma, stem cells, dermal grafts) have shown conflicting results in revision settings.
- Tendon transfer options (e.g., latissimus dorsi, teres major) are available for massive, irreparable tears.
Key Insights:
- A systematic surgical approach is crucial for improving success rates in revision rotator cuff repair.
- The efficacy of biologic augments in revision rotator cuff repair remains inconclusive.
- Tendon transfers offer viable solutions for specific complex rotator cuff deficiencies.
Outlook:
- Further research is needed to clarify the role and optimal application of biologic agents in revision rotator cuff repair.
- Continued refinement of surgical techniques and patient selection for tendon transfers will enhance management strategies.
- Personalized treatment plans integrating surgical, biologic, and reconstructive options are essential for optimizing patient outcomes.
Abstract:
Management of failed rotator cuff repair may be difficult, especially in young patients. Various nonmodifiable and modifiable patient factors, including age, tendon quality, rotator cuff tear characteristics, acute or chronic rotator cuff tear, bone quality, tobacco use, and medications, affect rotator cuff repair healing. Surgical variables, such as the technique, timing, tension on the repair, the biomechanical construct, and fixation, as well as the postoperative rehabilitation strategy also affect rotator cuff repair healing. Variable outcomes have been reported in patients who undergo revision rotator cuff repair; however, a systematic surgical approach may increase the likelihood of a successful outcome. Numerous cellular and mechanical biologic augments, including platelet-rich plasma, platelet-rich fibrin matrix, mesenchymal stem cells, and acellular dermal matrix grafts, have been used in rotator cuff repair; however, conflicting or inconclusive outcomes have been reported in patients who undergo revision rotator cuff repair with the use of these augments. A variety of tendon transfer options, including latissimus dorsi, teres major, lower trapezius, pectoralis minor, pectoralis major, combined pectoralis major and latissimus dorsi, and combined latissimus dorsi and teres major, are available for the management of massive irreparable rotator cuff tears. Ultimately, the optimization of surgical techniques and the use of appropriate biologic/tendon transfer techniques, if indicated, is the best method for the management of failed rotator cuff repair.
